Anti-platelet agregation: what did we learn from the evidence?
Hyperglycemia and insulin resistance, characteristics of patients with type 2 diabetes mellitus (T2D), produce platelet and endothelial alterations, increasing the risk of thrombotic events. The efficacy and benefit of antiplatelet therapy are well established in patients with atherosclerotic cardio...
Main Author: | |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Sello Editorial Lugones
2022-09-01
|
Series: | Revista de la Sociedad Argentina de Diabetes |
Subjects: | |
Online Access: | https://revistasad.com/index.php/diabetes/article/view/595 |